Papers by Amelia Cannon
NeuroTrialNER: An Annotated Corpus for Neurological Diseases and Therapies in Clinical Trial Registries (2024.emnlp-main)
Copied to clipboard
Simona Doneva, Tilia Ellendorff, Beate Sick, Jean-Philippe Goldman, Amelia Cannon, Gerold Schneider, Benjamin Ineichen
| Challenge: | Despite substantial investment, developing new treatments for neurological conditions is a challenging and often unsuccessful endeavour. |
| Approach: | They propose a corpus for named entity recognition that is annotated clinical trial summaries from ClinicalTrials.gov. |
| Outcome: | The proposed corpus is annotated for neurological diseases, therapeutic interventions, and control treatments and achieves a close-to-human performance. |